HD-OPM Archive
Topics › Statins

Statin-attributable abnormal liver tests occur in about 1 in 1,000 people

Louis Nervegna · Oct 04, 2025 · ♥ 11 reactions · 1 comments · original Facebook post
StatinsWeight, visceral & liver fat
↻ This is a repost. The main version (highest ranked) is Statin-related liver enzyme elevations are rare (about 1 in 1,000) and usually transient · Apr 03, 2026.
AI summary & key facts

Long-term liver enzyme elevations from statins are rare, and short-term rises usually resolve within months, which Louis describes as an adaptation rather than damage. A Harvard Health explainer says only about one in 1,000 statin users have an abnormal liver test attributable to the drug and routine monitoring is generally not needed.

Long term elevations of liver enzymes from statins are rare (1 in 1000). Short term elevations are more common. But these typically resolve within a few months. It’s a short term adaptation, not a sign of damage:

↪ Serious liver problems from statins are rare and routine liver monitoring is unnecessary

Newer research is showing that statins protect the liver in the long term:

↪ Statins may benefit chronic liver disease rather than harm it, per a review

↪ Statin use linked to lower liver cancer and decompensation in chronic liver disease

Research cited

How common are elevated liver enzymes in people taking a statin?

Quoted:

“Studies of very large numbers of people estimate that among those taking a statin, only one in 1,000 of them would have an abnormal liver test result attributable to the medication. Other studies found that abnormal test results were about as common in people who took a statin or a placebo. Since statins cause so few liver problems, and many other things—such as viral infections and drinking alcohol—can affect liver tests, most abnormal liver test results in people taking statins are unrelated.”

“When statin medications were first approved, doctors did periodic blood tests to check for liver injury. Three decades later, it is clear that serious liver injury from statins is a rare side effect and that routine blood testing does not help identify people at risk for statin-related liver problems. Therefore, routine monitoring is not a good use of money and time.”

“There have been rare reports of serious liver problems associated with statins, but the people this happens to often have liver disease already or were also taking other medications that worsen the effect of statins on the liver. Therefore, a single baseline liver test is recommended before starting on a statin, and periodic checks might be continued in people at high risk of problems.”

#statinsliverHD #statinsHD #liverHD

← newer: Statins may protect the liver in chronic liver disease, a reolder: Unhealthy plant-based diets raise heart disease risk, health →